Published in Antimicrob Agents Chemother on November 01, 1995
Combination antifungal therapy. Antimicrob Agents Chemother (2004) 3.49
Fluconazole disk diffusion susceptibility testing of Candida species. J Clin Microbiol (1998) 1.72
High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. Proc Natl Acad Sci U S A (2007) 1.62
Combination treatment of invasive fungal infections. Clin Microbiol Rev (2005) 1.59
Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models. Antimicrob Agents Chemother (1997) 1.24
In vitro interaction of flucytosine combined with amphotericin B or fluconazole against thirty-five yeast isolates determined by both the fractional inhibitory concentration index and the response surface approach. Antimicrob Agents Chemother (2002) 1.23
Cryptococcosis in AIDS. Postgrad Med J (2000) 1.10
Comparative effectiveness of induction therapy for human immunodeficiency virus-associated cryptococcal meningitis: a network meta-analysis. Open Forum Infect Dis (2015) 1.03
Stable phenotypic resistance of Candida species to amphotericin B conferred by preexposure to subinhibitory levels of azoles. J Clin Microbiol (1998) 0.94
Comparative evaluation of National Committee for Clinical Laboratory Standards broth macrodilution and agar dilution screening methods for testing fluconazole susceptibility of Cryptococcus neoformans. J Clin Microbiol (1998) 0.90
In vitro interaction between amphotericin B and azoles in Candida albicans. Antimicrob Agents Chemother (1996) 0.89
Inhibition of nucleotide biosynthesis potentiates the antifungal activity of amphotericin B. PLoS One (2014) 0.83
Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A. Ann Clin Microbiol Antimicrob (2012) 0.81
Voriconazole-induced inhibition of the fungicidal activity of amphotericin B in Candida strains with reduced susceptibility to voriconazole: an effect not predicted by the MIC value alone. Antimicrob Agents Chemother (2011) 0.76
Gene Expression and Identification Related to Fluconazole Resistance of Candida glabrata Strains. Osong Public Health Res Perspect (2010) 0.76
A method for testing for synergy with any number of agents. J Infect Dis (1978) 9.52
A three-dimensional model to analyze drug-drug interactions. Antiviral Res (1991) 6.58
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med (1992) 6.06
A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. N Engl J Med (1979) 5.87
Synergistic action of amphotericin B and 5-fluorocytosine against yeast-like organisms. Proc Soc Exp Biol Med (1971) 4.02
Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect Dis (1985) 4.00
A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group. N Engl J Med (1992) 3.65
Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. Ann Intern Med (1990) 3.26
Susceptibility testing of Cryptococcus neoformans: a microdilution technique. J Clin Microbiol (1992) 3.12
Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis. Antimicrob Agents Chemother (1991) 1.91
Strategic design and three-dimensional analysis of antiviral drug combinations. Antimicrob Agents Chemother (1993) 1.88
Amphotericin B nephrotoxicity. Drug Saf (1990) 1.74
Chemotherapeutic activity of 5-fluorocytosine and amphotericin B against Candida albicans in mice. Antimicrob Agents Chemother (1973) 1.47
Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine. Antimicrob Agents Chemother (1991) 1.01
Multifactorial analysis of effects of interactions among antifungal and antineoplastic drugs on inhibition of Candida albicans growth. Antimicrob Agents Chemother (1989) 0.93
Rational design of antiviral agents. Annu Rev Pharmacol Toxicol (1989) 0.89
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis (2001) 12.73
A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation (1975) 10.97
A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med (1994) 9.11
Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis (2000) 5.73
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet (2001) 4.97
Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy. Ann Intern Med (1978) 4.15
Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis (2001) 3.75
Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing. Clin Infect Dis (1996) 3.52
Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J (2000) 3.13
True and false left ventricular aneurysms. Propensity for the altter to rupture. Circulation (1975) 3.12
Susceptibility testing of Cryptococcus neoformans: a microdilution technique. J Clin Microbiol (1992) 3.12
Candida albicans RIM101 pH response pathway is required for host-pathogen interactions. Infect Immun (2000) 3.03
Ocular manifestations of Candida septicemia: review of seventy-six cases of hematogenous Candida endophthalmitis. Medicine (Baltimore) (1974) 2.97
Anomalies associated with coarctation of aorta: particular reference to infancy. Circulation (1970) 2.95
Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci U S A (1998) 2.88
Type 1/Type 2 immunity in infectious diseases. Clin Infect Dis (2000) 2.79
Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun (1995) 2.75
National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis (1999) 2.63
Adherence of Candida to cultured vascular endothelial cells: mechanisms of attachment and endothelial cell penetration. J Infect Dis (1985) 2.61
Response of newly hatched chicks to inanition. Vet Rec (1992) 2.57
National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species. Diagn Microbiol Infect Dis (1998) 2.56
PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. Proc Natl Acad Sci U S A (1994) 2.29
Congenital anomalies involving the coronary sinus. Circulation (1966) 2.29
Expression of specific binding sites on Candida with functional and antigenic characteristics of human complement receptors. J Immunol (1986) 2.28
Rupture of heart complicating myocardial infarction. Analysis of 40 cases including nine examples of left ventricular false aneurysm. Chest (1972) 2.22
Identification and characterization of a novel related adhesion focal tyrosine kinase (RAFTK) from megakaryocytes and brain. J Biol Chem (1995) 2.17
1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis (1997) 2.14
The use of Medpor coated tear drainage tube in conjunctivodacryocystorhinostomy. Eye (Lond) (2007) 2.13
Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. Clin Infect Dis (1995) 2.11
Adherence of Candida species to host tissues and plastic surfaces. Rev Infect Dis (1986) 2.11
Pretransplant IgG reactivity to apoptotic cells correlates with late kidney allograft loss. Am J Transplant (2014) 2.09
Right aortic arch. Types and associated cardiac anomalies. Circulation (1974) 2.08
Polysplenia: a review of 146 cases. Pediatr Cardiol (1983) 2.05
Ribulosediphosphate carboxylase from Chlamydomonas reinhardi: purification, properties and its mode of synthesis in the cell. Arch Biochem Biophys (1972) 2.00
Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science (1998) 1.97
Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut (2002) 1.96
Expression of the Candida albicans gene ALS1 in Saccharomyces cerevisiae induces adherence to endothelial and epithelial cells. Infect Immun (1998) 1.96
Congenital cardiac disease associated with polysplenia. A developmental complex of bilateral "left-sidedness". Circulation (1967) 1.96
Relative efficacy of oral analgesics after third molar extraction. Br Dent J (2004) 1.95
Differential synthesis of ribulosediphosphate carboxylase subunits. Biochem Biophys Res Commun (1970) 1.93
The spectrum of transposition of the great arteries: with specific reference to developmental anatomy of the conus. Circulation (1973) 1.93
Fat metabolism in higher plants. XXXI. Purification and properties of plant and bacterial acyl carrier proteins. J Biol Chem (1967) 1.87
Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans. J Biol Chem (1998) 1.84
Quantitation of amphotericin B with use of high-pressure liquid chromatography. J Infect Dis (1977) 1.83
Pathologic changes in aortic-coronary arterial saphenous vein grafts. Circulation (1971) 1.83
Biogenesis of Mitochondria in Germinating Peanut Cotyledons II. Changes in Cytochromes and Mitochondrial DNA. Plant Physiol (1967) 1.82
Nosocomial pneumonia caused by carbapenem-resistant Raoultella planticola: a case report and literature review. Infection (2015) 1.82
Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res (2000) 1.80
Thrombin-induced rabbit platelet microbicidal protein is fungicidal in vitro. Antimicrob Agents Chemother (1993) 1.80
Candida albicans stimulates cytokine production and leukocyte adhesion molecule expression by endothelial cells. Infect Immun (1996) 1.79
Promitochondria of anaerobically grown yeast. I. Isolation and biochemical properties. Biochemistry (1969) 1.79
Acute pain: individual patient meta-analysis shows the impact of different ways of analysing and presenting results. Pain (2005) 1.79
Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation. Am J Cardiol (1978) 1.78
Dissecting aortic aneurysm associated with congenital bicuspid aortic valve. Circulation (1978) 1.74
Comparison of the chemical properties of selenocysteine and selenocystine with their sulfur analogs. Arch Biochem Biophys (1967) 1.73
American families with Crohn's disease have strong evidence for linkage to chromosome 16 but not chromosome 12. Gastroenterology (1998) 1.71
Pulmonary vascular sling: report of seven cases and review of the literature. Pediatr Cardiol (1989) 1.68
Modulation of interactions of Candida albicans and endothelial cells by fluconazole and amphotericin B. Antimicrob Agents Chemother (1992) 1.67
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Ribulose diphosphate carboxylase. I. A factor involved in light activation of the enzyme. Biochem Biophys Res Commun (1969) 1.66
Cor triatriatum: study of 20 cases. Am J Cardiol (1975) 1.66
Congenital aneurysms adjacent to the anuli of the aortic and/or mitral valves. Chest (1982) 1.64
Correlation of the antemortem coronary arteriogram and the postmortem specimen. Circulation (1973) 1.64
Invasive candida infections--evolution of a fungal pathogen. N Engl J Med (1991) 1.64
Primary cardiac tumors: experience at the University of Minnesota. Thorac Cardiovasc Surg (1990) 1.61
Synergism of amphotericin B and 5-fluorocytosine for candida species. J Infect Dis (1975) 1.61
Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications. Diabet Med (1998) 1.61
Adherence of candida species to intravenous catheters. J Infect Dis (1983) 1.60
Adenosine 5'-diphosphate-glucose pyrophosphorylase from potato tuber. Significance of the N terminus of the small subunit for catalytic properties and heat stability. Plant Physiol (1995) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Hematogenous candida endophthalmitis in patients receiving parenteral hyperalimentation fluids. J Infect Dis (1981) 1.56
Essential role of the unfolded protein response regulator GRP78/BiP in protection from neuronal apoptosis. Cell Death Differ (2009) 1.55
Gabapentin for acute and chronic pain. Cochrane Database Syst Rev (2005) 1.55
Pulmonary arterial aneurysm. A pathologic study of five cases. Chest (1987) 1.54
Mechanism of fluconazole resistance in Candida krusei. Antimicrob Agents Chemother (1998) 1.52
Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators. Circulation (1998) 1.52
Cardiac malpositions. An overview based on study of sixty-five necropsy specimens. Circulation (1977) 1.51
Effects on cattle of transport by road for up to 15 hours. Vet Rec (1995) 1.51
Anatomic identification of so-called absent pulmonary artery. Circulation (1978) 1.49
TOM1 genes map to human chromosome 22q13.1 and mouse chromosome 8C1 and encode proteins similar to the endosomal proteins HGS and STAM. Genomics (1999) 1.49
Reduced virulence of HWP1-deficient mutants of Candida albicans and their interactions with host cells. Infect Immun (2000) 1.48
Communication between coronary sinus and left atrium. Br Heart J (1974) 1.48
Imiquimod for the treatment of genital warts: a quantitative systematic review. BMC Infect Dis (2001) 1.47
Diseases of the mitral valve in infancy. An anatomic analysis of 55 cases. Circulation (1971) 1.47
Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigators. Can J Cardiol (2000) 1.47
Measurement of neutrino oscillation with KamLAND: evidence of spectral distortion. Phys Rev Lett (2005) 1.46
Congenital aneurysm of left atrial appendage. Br Heart J (1981) 1.46
Isolated ventricular septal defect. Development basis for various types and presentation of classification. Chest (1970) 1.46
p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res (1994) 1.46
Elucidating the origins of nosocomial infections with Candida albicans by DNA fingerprinting with the complex probe Ca3. J Clin Microbiol (1999) 1.44